Partnerships – Seagen

To advance innovation and our mission to help oncology patients, we collaborate with other industry-leading biotechnology, pharmaceutical, and emerging biotech companies.

Natasha Hernday

Executive Vice President of Corporate Development

In it for life, together

Our partnerships focus on:

Innovative in-licensing opportunities at all development stages to diversify and grow our emerging global portfolio
Clinical and research collaborations that broaden the potential of our internal programs
Novel platform technologies that synergize with or expand our antibody–drug conjugate (ADC) capabilities in new and unique ways